Clinical utility gene card for: Proximal spinal muscular atrophy (SMA) - update 2015.
作者信息
Rudnik-Schöneborn Sabine, Eggermann Thomas, Kress Wolfram, Lemmink Henny H, Cobben Jan-Maarten, Zerres Klaus
机构信息
Institute of Human Genetics, Medical Faculty, RWTH Aachen, Aachen, Germany.
Institute of Human Genetics, University of Würzburg, Würzburg, Germany.
出版信息
Eur J Hum Genet. 2015 Nov;23(11). doi: 10.1038/ejhg.2015.90. Epub 2015 May 20.
Abstract
摘要
相似文献
1
Clinical utility gene card for: Proximal spinal muscular atrophy (SMA) - update 2015.近端脊髓性肌萎缩症（SMA）临床实用基因卡片 - 2015年更新版
Eur J Hum Genet. 2015 Nov;23(11). doi: 10.1038/ejhg.2015.90. Epub 2015 May 20.
2
[Point mutation analysis of SMN1 gene in patients with spinal muscular atrophy].脊髓性肌萎缩症患者中SMN1基因的点突变分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Apr;28(2):121-6. doi: 10.3760/cma.j.issn.1003-9406.2011.02.001.
3
Spinal muscular atrophy: newborn and carrier screening.脊髓性肌萎缩症：新生儿和携带者筛查。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):23-36, Table of Contents. doi: 10.1016/j.ogc.2010.03.001.
4
Compound heterozygous mutation in two unrelated cases of Chinese spinal muscular atrophy patients.两名中国脊肌萎缩症患者的两个无关联病例中的复合杂合突变。
Chin Med J (Engl). 2011 Feb;124(3):385-9.
5
Perspectives and diagnostic considerations in spinal muscular atrophy.脊髓性肌萎缩症的观点和诊断考虑。
Genet Med. 2010 Mar;12(3):145-52. doi: 10.1097/GIM.0b013e3181c5e713.
6
[Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].[上海地区4719名孕妇脊髓性肌萎缩症的携带者筛查]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Dec;30(6):670-2. doi: 10.3760/cma.j.issn.1003-9406.2013.06.008.
7
Diagnostic Testing for Patients with Spinal Muscular Atrophy.脊髓性肌萎缩症患者的诊断性检测。
Clin Lab Med. 2020 Sep;40(3):357-367. doi: 10.1016/j.cll.2020.05.005. Epub 2020 Jul 2.
8
Genetic therapy for spinal muscular atrophy.脊髓性肌萎缩症的基因治疗。
Nat Biotechnol. 2010 Mar;28(3):235-7. doi: 10.1038/nbt0310-235.
9
[Quantitative analysis of the genes determining spinal muscular atrophy].[决定脊髓性肌萎缩症的基因定量分析]
Ideggyogy Sz. 2009 Nov 30;62(11-12):390-7.
10
Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.SMN2启动子中的三核苷酸插入可能与脊髓性肌萎缩症的临床表型无关。
Brain Dev. 2015 Aug;37(7):669-76. doi: 10.1016/j.braindev.2014.10.006. Epub 2014 Oct 31.
引用本文的文献
1
A Novel Homozygous Variant of SETX Causes Ataxia with Oculomotor Apraxia Type 2.SETX基因的一种新型纯合变异导致2型动眼神经失用性共济失调。
J Clin Neurol. 2018 Oct;14(4):498-504. doi: 10.3988/jcn.2018.14.4.498. Epub 2018 Jul 12.
本文引用的文献
1
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.泛种族携带者筛查和产前诊断脊髓性肌萎缩症：超过 72400 例标本的临床实验室分析。
Eur J Hum Genet. 2012 Jan;20(1):27-32. doi: 10.1038/ejhg.2011.134. Epub 2011 Aug 3.
2
Technical standards and guidelines for spinal muscular atrophy testing.脊髓性肌萎缩症检测的技术标准和指南。
Genet Med. 2011 Jul;13(7):686-94. doi: 10.1097/GIM.0b013e318220d523.
3
Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene.西班牙脊髓性肌萎缩症的突变更新：745例非亲缘关系患者的分子特征及SMN1基因四个新突变的鉴定
Hum Genet. 2009 Feb;125(1):29-39. doi: 10.1007/s00439-008-0598-1. Epub 2008 Dec 3.
4
Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification.使用多重连接依赖探针扩增技术通过基因剂量进行脊髓性肌萎缩症基因分型。
Neurogenetics. 2006 Nov;7(4):269-76. doi: 10.1007/s10048-006-0051-3. Epub 2006 Jul 22.
5
Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations.使用一种鉴定SMN1微小突变的新策略对无纯合SMN1缺失的脊髓性肌萎缩症患者进行分子分析。
Hum Mutat. 2004 Nov;24(5):417-27. doi: 10.1002/humu.20092.
6
A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.对西班牙脊髓性肌萎缩症患者进行的基因和表型分析，这些患者携带c.399_402del AGAG突变，这是SMN1基因中最常见的微小突变。
Hum Mutat. 2003 Aug;22(2):136-43. doi: 10.1002/humu.10245.
7
Determination of SMN1 and SMN2 copy number using TaqMan technology.使用TaqMan技术测定SMN1和SMN2的拷贝数。
Hum Mutat. 2003 Jul;22(1):74-8. doi: 10.1002/humu.10221.
8
Genetic testing and risk assessment for spinal muscular atrophy (SMA).脊髓性肌萎缩症（SMA）的基因检测与风险评估
Hum Genet. 2002 Dec;111(6):477-500. doi: 10.1007/s00439-002-0828-x. Epub 2002 Oct 3.
9
Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.基于实时荧光定量PCR的SMN1和SMN2定量分析：脊髓性肌萎缩症携带者的快速、高度可靠检测及严重程度预测
Am J Hum Genet. 2002 Feb;70(2):358-68. doi: 10.1086/338627. Epub 2001 Dec 21.
10
Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.存活运动神经元拷贝数的定量分析：脊髓性肌萎缩症患者中微小SMN1突变的鉴定、基因型-表型相关性及对遗传咨询的意义。
Am J Hum Genet. 1999 May;64(5):1340-56. doi: 10.1086/302369.
Zotero 插件